Published in Eur Urol on March 19, 2008
Foreskin management: Survey of Canadian pediatric urologists. Can Fam Physician (2010) 1.62
Intravesical Liposomal Tacrolimus Protects against Radiation Cystitis Induced by 3-Beam Targeted Bladder Radiation. J Urol (2015) 0.92
The contemporary management of urethral strictures in men resulting from lichen sclerosus. Transl Androl Urol (2015) 0.75
Editorial comment on: Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. Eur Urol (2008) 0.75
Correspondence (letter to the editor): Adjuvant topical treatment with inflammation: suppressing medications should be given. Dtsch Arztebl Int (2011) 0.75
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell (2010) 6.47
Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell (2013) 2.43
Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem (2004) 2.17
Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement. Eur J Dermatol (2010) 2.03
Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc Natl Acad Sci U S A (2007) 1.97
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest (2006) 1.78
KITLG mutations cause familial progressive hyper- and hypopigmentation. J Invest Dermatol (2011) 1.59
Assisted reproductive techniques and risk of exstrophy-epispadias complex: a German case-control study. J Urol (2012) 1.55
Delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (Deflux) injection for treatment of vesicoureteral reflux in children: a case series. Urology (2013) 1.55
Pelvic-floor imaging using three-dimensional ultrasonography and magnetic resonance imaging in the long term follow-up of the bladder-exstrophy-epispadias complex. BJU Int (2009) 1.54
Seborrheic keratosis. J Dtsch Dermatol Ges (2008) 1.49
Granulomatous jellyfish dermatitis. J Dtsch Dermatol Ges (2007) 1.43
Recent advances in betalain research. Phytochemistry (2003) 1.41
Dysplastic melanocytic nevi of the lower leg: sex- and site-specific histopathology. Am J Dermatopathol (2010) 1.40
Gene expression profiling of melanocytes following Q-Switched Ruby laser irradiation. Dermatology (2008) 1.37
High frequency of FGFR3 mutations in adenoid seborrheic keratoses. J Invest Dermatol (2006) 1.37
Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population. Cancer Causes Control (2010) 1.28
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group. J Clin Oncol (2005) 1.27
The exstrophy-epispadias complex. Orphanet J Rare Dis (2009) 1.24
Occurence and clinical predictors of spasticity after ischemic stroke. Stroke (2010) 1.24
RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells. Int J Cancer (2008) 1.22
Relationship between tobacco control policies and the delivery of smoking cessation services in nonprofit HMOs. J Natl Cancer Inst Monogr (2005) 1.22
Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod Pathol (2006) 1.20
Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas. Mod Pathol (2005) 1.16
Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial. J Clin Oncol (2010) 1.14
Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. J Invest Dermatol (2007) 1.13
Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent. Dermatology (2003) 1.12
Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells. J Invest Dermatol (2006) 1.10
A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One (2012) 1.07
Loss of EphB6 expression in metastatic melanoma. Int J Oncol (2003) 1.06
The spectrum of reticulate pigment disorders of the skin revisited. Eur J Dermatol (2012) 1.06
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma. PPAR Res (2009) 1.06
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial. Melanoma Res (2007) 1.06
Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease. Clin J Am Soc Nephrol (2008) 1.05
A novel Mg(2+)-dependent O-methyltransferase in the phenylpropanoid metabolism of Mesembryanthemum crystallinum. J Biol Chem (2003) 1.02
Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review. Dermatoendocrinol (2011) 1.02
Pressure-induced volume expansion of zeolites in the natrolite family. J Am Chem Soc (2002) 1.01
FGFR3 mutations in benign skin tumors. Cell Cycle (2006) 1.00
Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proc Natl Acad Sci U S A (2010) 1.00
Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells. Int J Oncol (2005) 0.99
Biochemical and structural analysis of substrate promiscuity in plant Mg2+-dependent O-methyltransferases. J Mol Biol (2008) 0.99
IgE-mediated anaphylactic reaction induced by succinate ester of methylprednisolone. Ann Allergy Asthma Immunol (2002) 0.99
Screening rarely screened women: time-to-service and 24-month outcomes of tailored interventions. Prev Med (2003) 0.98
Structure of V(2)O(5)*nH(2)O xerogel solved by the atomic pair distribution function technique. J Am Chem Soc (2002) 0.98
Systems biology: a therapeutic target for tumor therapy. Cancer Microenviron (2008) 0.97
Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma. Cancer (2004) 0.97
Phenylpropanoid polyamine conjugate biosynthesis in Arabidopsis thaliana flower buds. Phytochemistry (2009) 0.97
Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitro. World J Gastroenterol (2005) 0.96
FGFR3 mutations in epidermal nevi and seborrheic keratoses: lessons from urothelium and skin. J Invest Dermatol (2007) 0.95
Screening for iron overload: lessons from the hemochromatosis and iron overload screening (HEIRS) study. Can J Gastroenterol (2009) 0.95
Progressive hyperpigmentation and generalized lentiginosis without associated systemic symptoms: a rare hereditary pigmentation disorder in south-east Germany. Acta Derm Venereol (2004) 0.94
New indications for established drugs: combined tumor-stroma-targeted cancer therapy with PPARgamma agonists, COX-2 inhibitors, mTOR antagonists and metronomic chemotherapy. Curr Cancer Drug Targets (2005) 0.94
Chiral three-dimensional microporous nickel aspartate with extended Ni-O-Ni bonding. J Am Chem Soc (2006) 0.94
Targeting T cells to hit B cells: successful treatment of cutaneous plasmacytosis with topical pimecrolimus. Dermatology (2006) 0.94
ORAI1 Ca(2+) channels control endothelin-1-induced mitogenesis and melanogenesis in primary human melanocytes. J Invest Dermatol (2012) 0.94
Synthesis of orthorhombic Mo-V-Sb oxide species by assembly of pentagonal Mo6O21 polyoxometalate building blocks. Angew Chem Int Ed Engl (2009) 0.93
Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology (2004) 0.93
Comparable effectiveness of endovenous laser ablation and high ligation with stripping of the great saphenous vein: two-year results of a randomized clinical trial (RELACS study). Arch Dermatol (2011) 0.92
Clonality of basal cell carcinoma arising in an epidermal nevus. New insights provided by molecular analysis. Dermatology (2008) 0.92
Genital and reproductive function in males after functional reconstruction of the exstrophy-epispadias complex--long-term results. Urology (2008) 0.92
Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry. Pigment Cell Melanoma Res (2014) 0.92
Identification of new genes associated with melanoma. Exp Dermatol (2011) 0.91
Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma. Exp Dermatol (2010) 0.91
Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations. Exp Dermatol (2010) 0.91
Numbness in clinical and experimental pain--a cross-sectional study exploring the mechanisms of reduced tactile function. Pain (2008) 0.91
Direct imaging of the MoVTeNbO M1 phase using an aberration-corrected high-resolution scanning transmission electron microscope. Angew Chem Int Ed Engl (2008) 0.91
Tapetum-specific location of a cation-dependent O-methyltransferase in Arabidopsis thaliana. Plant J (2008) 0.91
Phenotype severity in the bladder exstrophy-epispadias complex: analysis of genetic and nongenetic contributing factors in 441 families from North America and Europe. J Pediatr (2011) 0.89
Cloning and functional characterisation of two regioselective flavonoid glucosyltransferases from Beta vulgaris. Phytochemistry (2006) 0.88
Characterization of multidrug resistance 1a/P-glycoprotein knockout rats generated by zinc finger nucleases. Mol Pharmacol (2011) 0.88
Cowpox and a cat. Lancet (2005) 0.88
Non-framework cation migration and irreversible pressure-induced hydration in a zeolite. Nature (2002) 0.88
Long-term follow-up of male patients after reconstruction of the bladder-exstrophy-epispadias complex: psychosocial status, continence, renal and genital function. J Pediatr Urol (2009) 0.88
FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization. Mod Pathol (2007) 0.88
Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines. Anticancer Res (2012) 0.87
Ossifying renal tumor of infancy. J Pediatr Urol (2006) 0.87
Gene expression profile changes between melanoma metastases and their daughter cell lines: implication for vaccination protocols. J Invest Dermatol (2005) 0.87
Successful treatment of Rowell syndrome using oral cyclosporine A. Int J Dermatol (2011) 0.86
Eosinophilic meningitis due to Angiostrongylus cantonensis in Germany. J Travel Med (2009) 0.86
Skin manifestations in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Dermatoendocrinol (2010) 0.86
Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi. Mod Pathol (2006) 0.86
Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines. Oncol Rep (2008) 0.86
Multisegmental spondylitis due to Tropheryma whipplei: case report. Orphanet J Rare Dis (2009) 0.86
Comparison of LEP and QST and their contribution to standard sensory diagnostic assessment of spinal lesions: a pilot study. Neurol Sci (2011) 0.86
Super-hydrated zeolites: pressure-induced hydration in natrolites. Chemistry (2013) 0.86
FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes. Exp Cell Res (2010) 0.86
Hand-arm vibration syndrome: clinical characteristics, conventional electrophysiology and quantitative sensory testing. Clin Neurophysiol (2013) 0.85
Ephrin-B reverse signaling induces expression of wound healing associated genes in IEC-6 intestinal epithelial cells. World J Gastroenterol (2005) 0.85
Testicular tumors in patients with exstrophy-epispadias complex. J Urol (2012) 0.85
Noncontact laser catapulting: a basic procedure for functional genomics and proteomics. Methods Enzymol (2002) 0.85
A single amino acid determines position specificity of an Arabidopsis thaliana CCoAOMT-like O-methyltransferase. FEBS Lett (2013) 0.84
Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial. J Immunother (2010) 0.84
Pressure- and heat-induced insertion of CO2 into an auxetic small-pore zeolite. J Am Chem Soc (2011) 0.84
Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial). J Immunother (2011) 0.84
Discrimination of melanocytic tumors by cDNA array hybridization of tissues prepared by laser pressure catapulting. J Invest Dermatol (2004) 0.84
Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors. Arch Dermatol (2006) 0.83
Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment. J Rheumatol (2005) 0.83
Dermatoscopy of "dysplastic nevi": a beacon in diagnostic darkness. Eur J Dermatol (2006) 0.83
Cations modulate the substrate specificity of bifunctional class I O-methyltransferase from Ammi majus. FEBS Lett (2004) 0.83